Zinc Chloride for Injection Recalled Nationwide Due to Sterility Concerns
GenoGenix LLC is recalling all lots of Zinc Chloride for Injection nationwide due to lack of assurance of sterility. No illnesses or injuries have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product (injectable medication requiring sterility assurance) where no injuries have been reported. The source explicitly does not report any illnesses or injuries, and the hazard is precautionary (lack of assurance rather than confirmed contamination). Per the rubric, when illnesses/injuries are not reported and the hazard is theoretical, the maximum score is 3.
Plain-English summary
GenoGenix LLC has recalled all lots of Zinc Chloride for Injection, all strengths and presentations, distributed nationwide in the United States. The recall was initiated due to lack of assurance of sterility for these injectable products.
Zinc Chloride for Injection is used as a nutritional supplement in intravenous therapy. The absence of sterility assurance in injectable medications poses a potential contamination risk to patients receiving these products.
The recalled product was distributed nationwide to healthcare facilities. All lots currently within expiration date are affected by this recall. Healthcare providers and patients who have received this medication should consult their healthcare provider or the FDA for further guidance.
The recalled product
- Product
- Zinc Chloride for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.
- Manufacturer
- GenoGenix LLC
- Category
- Drug — Injectable
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27